John Foley is Reuters Breakingviews' U.S. editor. He has previously written and edited from London, Beijing and Hong Kong, and established Breakingviews’ first Asian bureau in 2009, subsequently running the European team from 2015 to 2017. Before joining Breakingviews in 2004, John worked as a copywriter for a London-based advertising agency. He read English Literature at Exeter College, Oxford.
Money is pouring into weed as valuations rise and legal barriers fall – nudged further by recent U.S. election results. Companies like Canopy, Aurora and MedMen are starting to take on a veneer of acceptability. That doesn’t make them good investments, but it’s progress.
Its CEO is out and Bart Becht has resigned as chair of the perfumier, which fumbled a $12.5 bln deal. A fresh start is good, but such chaos doesn’t befit a company with so many consumer-goods experts on its board. It does no favors for main owner and serial dealmaker JAB, either.
The Wall Street bank elevated a measly 69 staff to partner level, even though its workforce and earnings are growing. Making the coveted title scarcer is intended to give staff a nudge. Ensuring it’s more accessible to people Goldman could use more of should be equally important.